Trimarchi Thomas 4
4 · BridgeBio Pharma, Inc. · Filed Aug 8, 2024
Insider Transaction Report
Form 4
Trimarchi Thomas
President and CFO
Transactions
- Award
Stock Option (Right to Buy)
2024-08-06+3,160→ 3,160 totalExercise: $24.87Exp: 2034-08-05→ Common Stock (3,160 underlying) - Award
Common Stock
2024-08-06+19,003→ 413,859 total
Footnotes (3)
- [F1]Grant of restricted stock units (RSUs) under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest in 16 quarterly installments beginning on August 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The stock option shall vest in 16 quarterly installments beginning on August 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.